Should Cardiovascular Preventive Therapy Be Over-the-Counter?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2021-09, Vol.78 (11), p.1124-1126
Hauptverfasser:	Pagidipati, Neha J, Peterson, Eric D
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular System Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Nonprescription Drugs
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	1126
container_issue	11
container_start_page	1124
container_title	Journal of the American College of Cardiology
container_volume	78
creator	Pagidipati, Neha J Peterson, Eric D
description
doi_str_mv	10.1016/j.jacc.2021.07.020
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2571916380</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2571916380</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-e21b28a186ea2795323659d98195aa7d4e1d7b251d3a8f945cd5515d7ac5e673</originalsourceid><addsrcrecordid>eNo9kM9LwzAcxYMobk7_AQ_So5fUb5KlaQ4iWvwFgwnuHrLkO9bSrTNpC_vv7dj09N7hvcfjQ8gtg5QByx6qtLLOpRw4S0GlwOGMjJmUORVSq3MyBiUkZaDViFzFWAFAljN9SUZiKkEMfkwev9dNV_uksMGXTW-j62obkq-APW7bssdkscZgd_vkBZN5j4G2a6RF021bDE_X5GJl64g3J52Qxdvrovigs_n7Z_E8o06AaClytuS5ZXmGlistBReZ1F4PZ6S1yk-RebXkknlh85WeSuelZNIr6yRmSkzI_XF2F5qfDmNrNmV0WNd2i00XDZeKaZaJHIYoP0ZdaGIMuDK7UG5s2BsG5kDNVOZAzRyoGVBmoDaU7k773XKD_r_yh0n8Arq8aB4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2571916380</pqid></control><display><type>article</type><title>Should Cardiovascular Preventive Therapy Be Over-the-Counter?</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Pagidipati, Neha J ; Peterson, Eric D</creator><creatorcontrib>Pagidipati, Neha J ; Peterson, Eric D</creatorcontrib><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2021.07.020</identifier><identifier>PMID: 34503681</identifier><language>eng</language><publisher>United States</publisher><subject>Cardiovascular System ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Nonprescription Drugs</subject><ispartof>Journal of the American College of Cardiology, 2021-09, Vol.78 (11), p.1124-1126</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c303t-e21b28a186ea2795323659d98195aa7d4e1d7b251d3a8f945cd5515d7ac5e673</citedby><cites>FETCH-LOGICAL-c303t-e21b28a186ea2795323659d98195aa7d4e1d7b251d3a8f945cd5515d7ac5e673</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34503681$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pagidipati, Neha J</creatorcontrib><creatorcontrib>Peterson, Eric D</creatorcontrib><title>Should Cardiovascular Preventive Therapy Be Over-the-Counter?</title><title>Journal of the American College of Cardiology</title><addtitle>J Am Coll Cardiol</addtitle><subject>Cardiovascular System</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors</subject><subject>Nonprescription Drugs</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM9LwzAcxYMobk7_AQ_So5fUb5KlaQ4iWvwFgwnuHrLkO9bSrTNpC_vv7dj09N7hvcfjQ8gtg5QByx6qtLLOpRw4S0GlwOGMjJmUORVSq3MyBiUkZaDViFzFWAFAljN9SUZiKkEMfkwev9dNV_uksMGXTW-j62obkq-APW7bssdkscZgd_vkBZN5j4G2a6RF021bDE_X5GJl64g3J52Qxdvrovigs_n7Z_E8o06AaClytuS5ZXmGlistBReZ1F4PZ6S1yk-RebXkknlh85WeSuelZNIr6yRmSkzI_XF2F5qfDmNrNmV0WNd2i00XDZeKaZaJHIYoP0ZdaGIMuDK7UG5s2BsG5kDNVOZAzRyoGVBmoDaU7k773XKD_r_yh0n8Arq8aB4</recordid><startdate>20210914</startdate><enddate>20210914</enddate><creator>Pagidipati, Neha J</creator><creator>Peterson, Eric D</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210914</creationdate><title>Should Cardiovascular Preventive Therapy Be Over-the-Counter?</title><author>Pagidipati, Neha J ; Peterson, Eric D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-e21b28a186ea2795323659d98195aa7d4e1d7b251d3a8f945cd5515d7ac5e673</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Cardiovascular System</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors</topic><topic>Nonprescription Drugs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pagidipati, Neha J</creatorcontrib><creatorcontrib>Peterson, Eric D</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pagidipati, Neha J</au><au>Peterson, Eric D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Should Cardiovascular Preventive Therapy Be Over-the-Counter?</atitle><jtitle>Journal of the American College of Cardiology</jtitle><addtitle>J Am Coll Cardiol</addtitle><date>2021-09-14</date><risdate>2021</risdate><volume>78</volume><issue>11</issue><spage>1124</spage><epage>1126</epage><pages>1124-1126</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><cop>United States</cop><pmid>34503681</pmid><doi>10.1016/j.jacc.2021.07.020</doi><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0735-1097
ispartof	Journal of the American College of Cardiology, 2021-09, Vol.78 (11), p.1124-1126
issn	0735-1097 1558-3597
language	eng
recordid	cdi_proquest_miscellaneous_2571916380
source	MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects	Cardiovascular System Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Nonprescription Drugs
title	Should Cardiovascular Preventive Therapy Be Over-the-Counter?
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T12%3A14%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Should%20Cardiovascular%20Preventive%20Therapy%20Be%20Over-the-Counter?&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Pagidipati,%20Neha%20J&rft.date=2021-09-14&rft.volume=78&rft.issue=11&rft.spage=1124&rft.epage=1126&rft.pages=1124-1126&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2021.07.020&rft_dat=%3Cproquest_cross%3E2571916380%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2571916380&rft_id=info:pmid/34503681&rfr_iscdi=true